Mirtazapine Cyano Impurity (Oxalate salt) CAS 331815-15-7
| CAS No. | 331815-15-7 |
| Molecular Formula | C17H18N4 |
| Molecular Weight | 278.35 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Mirtazapine Cyano Impurity (Oxalate salt) is closely related to a nitrogen-containing heterocyclic scaffold, a nitrile group in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Mirtazapine Cyano Impurity (Oxalate salt) (CAS 331815-15-7) is a high-purity analytical reference standard with the molecular formula C17H18N4 and a molecular weight of 278.35 g/mol.
Owing to a nitrogen-containing heterocyclic scaffold, a nitrile group, Mirtazapine Cyano Impurity (Oxalate salt) is typically pale yellow to yellow low-melting solid. Its solid-state physicochemical attributes — including a molecular weight of 278.35 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Mirtazapine Cyano Impurity (Oxalate salt) under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C17H18N4 |
| Molecular Weight | 278.35 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Nitrogen Atoms | 4 |
Related Mirtazapine Standards
- Mirtazapine Impurity 23 (CAS 61337-88-0)
- Mirtazapine EP Impurity C (CAS 191546-96-0)
- Mirtazapine EP Impurity F (CAS 191546-97-1)
- Mirtazapine EP Impurity A (CAS 155172-12-6)
- Mirtazapine Impurity 3 (CAS 852524-23-3)
- Mirtazapine Impurity 2 (CAS CATO-C4X-15112)
- Mirtazapine Impurity 25 (CAS CATO-C4X-151125)
- Mirtazapine EP Impurity B (CAS 61337-89-1)
Recommended Standards
- Methyl 4-((4-(2-hydroxyethyl)piperazin-1-yl)methyl)benzoate (CAS 415952-34-0)
- N-((1-Ethylpyrrolidin-2-yl)methyl)-4-methoxy-2-methylpyrimidine-5-carboxamide (CAS 72412-52-3)
- H-Leu-D-Phe-OH (CAS 21675-59-2)
- N-(1-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-methylprop-1-en-1-yl)-N-methylaniline (CAS 305861-35-2)
- 2-Methyl-3-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carbaldehyde (CAS 151163-96-1)
- 3-(3-Chlorophenyl)-2-(thiophen-2-yl)prop-2-enoic acid (CAS 1017114-62-3)
- 1-(6-Methoxy-3-methylbenzofuran-2-yl)ethanone (CAS 23911-57-1)
- Levocabastine EP Impurity A (CAS CATO-C4X-22891)
- 2-Aminocyclooctanone (CAS 787485-54-5)
- 6,7-Dihydro-1H-indazol-5(4H)-one (CAS 1196154-00-3)
- 1-methyl-6-oxopiperidine-3-carboxylic acid (CAS 22540-51-8)
- Tert-butyl 3-bromo-1H-pyrazolo[3,4-c]pyridine-1-carboxylate (CAS 1286755-24-5)
- 3-(Cyclopropylmethyl)-7-(4-phenylpiperidin-1-yl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine (CAS 1254977-87-1)
- Semaglutide impurity 83 (CAS CATO-C4X-222683)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com